Inventor
MICHAL EUGENE
US16 patents
⚠️ This page may combine multiple inventors who share the name “MICHAL EUGENE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ADVANCED CARDIOVASCULAR SYSTEM
4 patentsUS7732190B2Jun 8, 2010
Modified two-component gelation systems, methods of use and methods of manufacture
ADVANCED CARDIOVASCULAR SYSTEM56 citations98
US8906394B2Dec 9, 2014
Hyaluronic acid based copolymers
ADVANCED CARDIOVASCULAR SYSTEM1 citations62
US8846836B2Sep 30, 2014
Hyaluronic acid based copolymers
ADVANCED CARDIOVASCULAR SYSTEM2 citations62
US8734817B2May 27, 2014
Hyaluronic acid based copolymers
ADVANCED CARDIOVASCULAR SYSTEM1 citations62
ABBOTT CARDIOVASCULAR SYSTEMS
4 patentsUS7364657B2Apr 29, 2008
Integrated system for on-site cell acquisition, processing, and delivery
ABBOTT CARDIOVASCULAR SYSTEMS101 citations97
US8377033B2Feb 19, 2013
Methods of modifying myocardial infarction expansion
ABBOTT CARDIOVASCULAR SYSTEMS19 citations92
US8038991B1Oct 18, 2011
High-viscosity hyaluronic acid compositions to treat myocardial conditions
ABBOTT CARDIOVASCULAR SYSTEMS30 citations90
US9101697B2Aug 11, 2015
Hyaluronic acid based copolymers
ABBOTT CARDIOVASCULAR SYSTEMS0 citations51
MICHAL EUGENE
4 patentsUS8187621B2May 29, 2012
Methods and compositions for treating post-myocardial infarction damage
MICHAL EUGENE22 citations89
US8486387B2Jul 16, 2013
Modified two-component gelation systems, methods of use and methods of manufacture
MICHAL EUGENE7 citations83
US8486386B2Jul 16, 2013
Modified two-component gelation systems, methods of use and methods of manufacture
MICHAL EUGENE8 citations83
US8609126B2Dec 17, 2013
Methods and compositions for treating post-myocardial infarction damage
MICHAL EUGENE8 citations81